|
MECHANISMS OF EUKARYOTIC
RNA EXPRESSION AND FUNCTIONS OF THE HUMAN LA ANTIGEN
|
|||
| Richard
J. Maraia, M.D., Head, Section on Molecular
and Cell Biology Robert V. Intine, Ph.D., Staff Scientist Ying Huang, Ph.D., Visiting Associate Elena Schwartz, Ph.D., Postdoctoral Fellow Claire Vech, M.S., Technician Edward McGillicuddy, B.S., Postbaccalaureate Fellow Amy Mozlin, B.S., Postbaccalaureate Fellow Ipsita Mukhergee, B.S., Technical Training Fellow Evan D. Muse, B.S., Graduate Student Gretchen Nelson, B.S., Postbaccalaureate Fellow Kristina Treanor, B.S., Postbaccalaureate Fellow |
![]() |
||
|
We study mechanisms of eukaryotic RNA biogenesis and functions of the
human La antigen, for which transcription by RNA polymerase III (Pol III)
serves as a model system of gene expression. Transfer RNAs are the Pol
III transcripts currently under most intense study. The precursors of
tRNAs are synthesized as nascent transcripts that undergo a maturation
process involving a series of coordinated enzymatic and intracellular
trafficking activities that ultimately deliver a functional tRNA to the
ribosomes. Our interests focus on a few of the individual steps in RNA
production (e.g., transcription initiation and termination as well as
RNA processing and intranuclear trafficking), including coordination of
the sequential steps in time and space within the cell. In particular,
we have focused on the human La antigen, a protein that is a target of
autoantibodies in patients suffering from certain autoimmune disorders
(e.g., systemic lupus erythematosus). The human La antigen is a nuclear-cytoplasmic
shuttling protein that also binds to the 5' untranslated regions of certain
mRNAs, regulating and coordinating key steps in RNA expression. We use
modern genetics, molecular biology, and biochemical approaches and rely
heavily on analytical biochemistry as well as tissue culture, yeast systems,
and transgenic and gene-altered mice. Functions of the Human La Antigen in RNA Expression We mapped the major phosphorylation site of La to serine 366 (S366) and
showed that the phosphorylation interferes with Las ability to interact
with the initiating pppG of the nascent transcript and to activate transcription
initiation by Pol III, implying that these activities are mechanistically
related. The results suggest an La cycle of transcription
and post-transcriptional regulation that is mediated in part by the C-terminal
domain (CTD) of La. Others have recently shown that La is dephosphorylated
at S366 during early apoptosis. We have developed two sets of monospecific
antibodies that can distinguish phosphoS366 (pLa) from nonphospohoS366
(npLa). We could demonstrate that npLa and pLa exhibit distinct subnuclear
localizations (nucleoplasm versus nucleoli) and that they are differentially
associated with certain RNAs in vivo. Our data point to several trafficking signals in La that control nuclear,
nucleolar, and cytoplasmic localization. Using a tRNA suppressor reporter
system, we have identified an intranuclear trafficking defect that is
associated with detrimental disordering of tRNA processing activities.
In this case, La recognizes and normally binds to its substrate pre-tRNAs,
but the defect causes improper routing in the nucleus, resulting in the
accumulation of a dead-end tRNA processing intermediate that is nonfunctional.
Our studies revealed that La traffics through the nucleus and is exported
to the cytoplasm, and have uncovered an unexpected nuclear export signal
(NES) in La. The existence of an efficient, carrier-mediated NES system
for La is surprising because the established functions of La in Pol III
transcript biogenesis are entirely intranuclear. Further characterization
revealed that both the nuclear export pathway used for La and other features
of Las NES function are characteristic of some RNA-binding proteins
that carry certain mRNAs to the cytoplasm. Accordingly, we have begun
to extend our studies to include examination of the involvement of La
in the expression of certain target mRNAs, especially those whose expression
is critical to growth and development. We have shown that the tRNA gene under study requires the La protein for efficient expression in vivo. Many important questions remain, such as the mechanistic link between La and pol III termination; whether the lack of reporter genederived transcripts in the La-minus strain is attributable to a defect in transcription rate, nascent RNA processing, or both; and the nature of other factors that contribute to the La-dependent activation of this tRNA gene. Transcription Initiation by RNA Polymerase III |
|||
|
SELECTED PUBLICATIONS
|
|||